Berry Global has brough further innovation to the healthcare market with the RS01 single-dose Dry Powder Inhaler (DPI) from the newly-created Berry Global Healthcare, and it is now available with built-in sensors and digital capabilities.
Berry Global’s leading single-dose DPI goes digital
The new RS01X tracks inhaler use and connects to a companion app which provides personalised guidance to improve adherence and inhaler technique.
Berry has put in place a global agreement with Amiko Digital Health and the RS01X is integrated with Amiko’s Respiro, a digital medicine platform for use with connected inhalers that combines data, AI, and digital experiences to upgrade respiratory care.
This has resulted from the growing trend towards precision medicine, where targeted, individualised care is provided for and tailored to each patient.
Vincent Clauzel, Managing Director, Berry Global – Care Unit, said: “The introduction of the RS01X is a significant milestone for Berry Healthcare globally, as well as for innovation in respiratory devices. We are very excited to have established a successful and very close partnership with Amiko to achieve this.”
The RS01X automatically captures, stores and encrypts objective inhaler data, including user generated inhalations through the inhaler, and connects wirelessly to the Respiro app.
In previous clinical studies, the Respiro platform delivered improvements in controller medication adherence by up to 37 per cent and in optimal inhaler technique by up to 42 per cent.
The connected inhaler retains the user-friendly features of the original RS01, making it suitable for all age groups. It provides consistent dosage delivery with easy refilling. A built-in battery means no charging is required for the inhaler throughout its usage.
Martijn Grinovero, Chief Commercial Officer at Amiko, added: “We are thrilled to have found a partner with the vision, ambition and market experience of Berry Global. We are extremely excited about the RS01X and Respiro becoming available to patients and care providers at a scale that truly makes a difference.”
Berry Healthcare comprises 35 manufacturing locations throughout Europe, offering a wide number of specialisations in drug administration, including oral, nasal, pulmonary, and ophthalmic, along with an extensive range of packs for all types of pharmaceutical and medical products.